Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Angela J. Hanson"'
Autor:
Peter Thomas, Manon Leclerc, Kira Evitts, Caitlin Brown, Wyatt Miller, Angela J. Hanson, William A. Banks, Laura Gibbons, Kimiko Domoto‐Reilly, Suman Jayadev, Ge Li, Elaine Peskind, Jessica E. Young, the Consortium for the early identification of Alzheimer's disease‐Quebec (CIMA‐Q), Frederic Calon, Elizabeth M. Rhea
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 16, Iss 2, Pp n/a-n/a (2024)
Abstract INTRODUCTION Brain insulin resistance and deficiency is a consistent feature of Alzheimer's disease (AD). Insulin resistance can be mediated by the surface expression of the insulin receptor (IR). Cleavage of the IR generates the soluble IR
Externí odkaz:
https://doaj.org/article/a96035dfbb90424f8896334c2188590c
Autor:
Angela J. Hanson, Katya B. Rubinow
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1681-1688 (2021)
Abstract Alzheimer’s disease (AD) is the most common form of dementia, and its prevalence is increasing rapidly. According to the Alzheimer’s Association, over 5 million adults in the United States over the age of 65 years currently have AD, and
Externí odkaz:
https://doaj.org/article/473c3b7f586742bb9bfa26df6d454560
Autor:
Angela J. Hanson, William A. Banks, Lisa F. Bettcher, Robert Pepin, Daniel Raftery, Sandi L. Navarro, Suzanne Craft
Publikováno v:
Metabolites, Vol 13, Iss 4, p 569 (2023)
Brain glucose hypometabolism is an early sign of Alzheimer’s disease (AD), and interventions which offset this deficit, such as ketogenic diets, show promise as AD therapeutics. Conversely, high-fat feeding may exacerbate AD risk. We analyzed the m
Externí odkaz:
https://doaj.org/article/e5a770324cf447bb9fdd1471aa625b1a
Autor:
Han Ly, Nirmal Verma, Savita Sharma, Deepak Kotiya, Sanda Despa, Erin L. Abner, Peter T. Nelson, Gregory A. Jicha, Donna M. Wilcock, Larry B. Goldstein, Rita Guerreiro, José Brás, Angela J. Hanson, Suzanne Craft, Andrew J. Murray, Geert Jan Biessels, Claire Troakes, Henrik Zetterberg, John Hardy, Tammaryn Lashley, AESG, Florin Despa
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 7, Iss 1, Pp n/a-n/a (2021)
Abstract Introduction This study assessed the hypothesis that circulating human amylin (amyloid‐forming) cross‐seeds with amyloid beta (Aβ) in early Alzheimer's disease (AD). Methods Evidence of amylin‐AD pathology interaction was tested in br
Externí odkaz:
https://doaj.org/article/0b8ec51226584175b13b3295b59f5cd5
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 6, Iss 1, Pp 78-89 (2016)
Background: Glucose intolerance and apolipoprotein ε4 allele (E4+) are risk factors for Alzheimer's disease (AD). Insulin sensitizers show promise for treating AD, but are less effective in E4+ individuals. Little is known about how the APOE genotyp
Externí odkaz:
https://doaj.org/article/2460bb5f8e3a4f50b3c5f1de622080ba
Publikováno v:
Alzheimer's & Dementia. 18
Publikováno v:
Alzheimer's & Dementia. 18
Publikováno v:
J Am Geriatr Soc
Background To demonstrate feasibility and utility of the iPad version of the NIH Toolbox Cognition Battery (NIHTB-CB) in a clinical trial of older adults. Methods Fifty-one adults, aged 55 and older without dementia were tested twice on NIHTB-CB and
Autor:
Laura D. Baker, James B. Leverenz, Ashley H. Sanderlin, Siobhan M. Hoscheidt, Suzanne Craft, Angela J. Hanson, Seth D. Friedman, Youngkyoo Jung, Samuel N. Lockhart, Thomas C. Register, Christopher T. Whitlow, Derek Kellar
Publikováno v:
Alzheimer's & Dementia. 18:457-468
Introduction Mid-life dietary patterns are associated with Alzheimer's disease (AD) risk, although few controlled trials have been conducted. Methods Eighty-seven participants (age range: 45 to 65) with normal cognition (NC, n = 56) or mild cognitive
Publikováno v:
Alzheimer's & Dementia. 17